Send us a text

In part two of our Truth on Diabetes series, you will understand diabetes treatments as we sit down with Dr. Arpeta Gupta to dissect the latest guidelines and the transformative impact of newer diabetes medications. We will discuss how SGLT2 inhibitors and GLP-1 agonists are not only enhancing glycemic control but also delivering critical cardiovascular and renal benefits. We revisit the troubled history of TZD drugs like Avandia and contrast it with the safety profiles of today's leading medications. Drs. Gupta and Koren dive into the complexities of managing diabetes care across multiple specialties and share actionable strategies to improve interdisciplinary communication for better patient outcomes.

Navigating the hurdles of diabetes treatment access is no small feat, and we tackle this issue head-on by examining how insurance policies and cost barriers affect patient care. From the implications of prior authorization and step therapy to the financial strain on patients, particularly those on federal plans, we leave no stone unturned. We also explore the exciting potential of federal drug price negotiations and recent strides in lowering insulin costs. The significance of selecting therapies that safeguard end organs and the advantages of participating in clinical trials for cutting-edge treatments are underscored, ensuring you leave with a comprehensive view of the future landscape of diabetes care.

Koren's Key Three Takeaways:

• Guidelines and Effectiveness of Diabetes Drugs
• Diabetes treatment access and insurance
• Challenges and Future of Diabetes Treatment

Recording Date: June 19, 2024

Be a part of advancing science by participating in clinical research.

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn

Want to learn more checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Music: Storyblocks - Corporate Inspired

Thank you for listening!

Send us a text

Ever wondered how participating in clinical trials could unveil hidden health concerns you didn't even know existed? Join us on this week's MedEvidence Monday Minute as Dr. Michael Koren unravels the mysteries behind cutting-edge medical research. From cardiovascular prevention to vaccine development, discover how these groundbreaking studies can provide you with not only pioneering treatments but also comprehensive health evaluations.

Recording Date August 26, 2024

Be a part of advancing science by participating in clinical research.

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn

Want to learn more checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Music: Storyblocks - Corporate Inspired

Thank you for listening!

Send us a text

What if understanding the nuances between different types of diabetes could revolutionize your approach to prevention and management? Join us as we unravel the latest changes in diabetic guidelines with the esteemed Dr. Arpeta Gupta, a leading endocrinologist. Dr. Gupta expertly demystifies the distinctions between type 1, type 2, and the emerging concept of type 3 diabetes. Learn how type 1 diabetes, often seen in children, is marked by pancreatic damage leading to insulin dependence, while type 2 diabetes involves insulin resistance primarily in the liver. Discover the complexities of type 3 diabetes, which arises from extended type 2 diabetes or other conditions like chemotherapy and viral infections, resulting in an autoimmune response predominantly in older adults. This essential discussion highlights the importance of accurately classifying diabetes for effective prevention and management strategies.

In the second segment, released on August 28, 2024, we delve into the powerful synergy between internal medicine subspecialties and how their integration significantly enhances patient care. We highlight the importance of protecting various organ systems and explore the dynamic collaboration among medical professionals. We also spotlight the pivotal role of clinical trials, focusing on the development journey of Semaglutide, widely known as Ozempic. Dr. Gupta shares invaluable insights on its history and advancement, emphasizing the impact of clinical research in pioneering new treatments. Don’t miss this compelling episode of MedEvidence, where we bring you the truth behind medical research with unbiased, evidence-based facts.

Catch Koren's Key Three Takeaways:

• Understanding Diabetic Guidelines and Treatments
• Meet Type 3 Diabetes
• Interdisciplinary Medicine and Clinical Trials

Recording Date: June 19, 2024

Be a part of advancing science by participating in clinical research.

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn

Want to learn more checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Music: Storyblocks - Corporate Inspired

Thank you for listening!